Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. 2invest AG
  6. News
  7. Andere Sprachen
    2INV   DE000A3H3L44   A3H3L4

2INVEST AG

(A3H3L4)
  Bericht
Verzögert Xetra  -  17:36 23.09.2022
9.220 EUR    0.00%
11.08.2invest AG meldet Ergebnis für das Halbjahr zum 30. Juni 2022
CI
08.08.2INVEST : Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
PU
21.07.2INVEST : Vorläufiges Halbjahresergebnis zum 30. Juni 2022 und Prognoseänderung für das Geschäftsjahr 2022
PU
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenDerivateFonds 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über 2INVEST AG
07.09.THETA GOLD MINES LIMITED (ASX : TGM) Issue of New Call Options to 2Invest AG
11.08.2invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
13.05.THETA GOLD MINES LIMITED (ASX : TGM) Option to Extend Secure Bond Maturity Date
20.04.2invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
23.03.Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from C..
16.03.Kither Biotech s.r.l. announced that it has received €18.5 million in funding from..
25.02.2INVEST : Preliminary annual results as of 31 December 2021
20212INVEST : Change of forecast for the financial year 2021
2021Revocation of the admission to the Prime Standard
2021Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Ca..
20212Invest Ag Reports Earnings Results for the Half Year Ended June 30, 2021
20212INVEST : Preliminary half-year results as of 30.06.2021
20212INVEST : Report of the Supervisory Board of 2invest AG for the financial year from 1 Janu..
20214BASEBIO : Quarterly statement as at 31 March 2021 published
20214BASEBIO : Application for change from Prime Standard to General Standard
20214BASEBIO : Implementation of the reverse stock split of 4basebio AG
20214BASEBIO : KROMI takeover offer will not be pursued further
20214BASEBIO : Preliminary annual result as of 31.12.2020
20214Basebio Ag Provides Earnings Guidance for the Full Year Ended December 31, 2020
20214BASEBIO : Further processing of the spin-off
20214BASEBIO : reports on results of the Extraordinary General Meeting 2021
20214BASEBIO : Decision to make a public takeover offer to the shareholders of KROMI Logistik ..
20214basebio AG cancelled the acquisition of KROMI Logistik AG.
20204basebio AG Announces Board Changes
20204BASEBIO : Update regarding the status of the settlement of the spin-off
20204BASEBIO : reports on registration of spin-off and explains further settlement process
20204basebio AG completed the spin-off of Genomics and DNA manufacturing business.
20204BASEBIO : reports change in Supervisory Board and new appointment to the Executive Manage..
20204basebio AG Announces Board Changes
20204Basebio Ag Reports Earnings Results for the Nine Months Ended September 30, 2020
20204BASEBIO : reports first nine months of 2020 financial results
2020EXPEDEON : 4basebio reports on results of Extraordinary General Meeting 2020
2020EXPEDEON : 4basebio announces share capital reduction by way of reverse stock split
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : 4basebio AG signs term sheet for investment in nanoparticle-based gene therapy ..
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : 4basebio comments on the takeover bid of Sparta AG
20204BASEBIO AG : 4basebio comments on the takeover bid of Sparta AG
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Mitteilung über Eigengeschäfte von Führungskräften gem. Art. 19 MAR
2020EXPEDEON : 4basebio AG announces process for spin-off and separate stock market listing fo..
20204BASEBIO : announces process for spin-off and separate stock market listing for its DNA bu..
2020The Board of Directors of 4basebio AG announced the spin-off of unknown majority stake ..
2020TRANSCRIPT : 4basebio AG, H1 2020 Earnings Call, Aug 13, 2020
20204basebio AG Reaffirms Earnings Guidance for the Full Year of 2020
20204BASEBIO AG : 4basebio AG reports first six months of 2020 financial results
20204Basebio Ag Reports Earnings Results for the Second Quarter Ended June 30, 2020
20204BASEBIO AG : 4basebio informs about takeover bid by Sparta AG
2020SPARTA AG (DB : SPT6) made an offer to acquire remaining 95.8% stake in 4basebio AG for &#..
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
2020EXPEDEON : Managers' transactions announcement according to article 19 MAR
20204BASEBIO AG : 4basebio reports on results of Annual General Meeting 2020
20204BASEBIO AG : Notification and public disclosure of transactions by persons
20204BASEBIO AG : Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio's contribu..
20204BASEBIO AG : 4basebio AG reports first quarter 2020 financial results
20204basebio AG Reaffirms Earning Guidance for the Fiscal Year 2020
2020Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019.
2020TRANSCRIPT : 4basebio AG, 2019 Earnings Call, Apr 24, 2020
20204BASEBIO AG : 4basebio AG Reports positive Financial Results for Fiscal Year 2019 - Financ..
20204Basebio Ag Reports Earnings Results for the Full Year Ended December 31, 2019
2020Tranche Update on 4basebio AG's Equity Buyback Plan announced on December 19, 2019.
20204BASEBIO AG : 4basebio provides Phi29 DNA polymerase variants and expertise to develop imp..
20204basebio AG Provides Phi29 DNA polymerase variants and expertise to develop improved de..
20204BASEBIO AG : 4basebio AG resolves on capital reduction by way of redemption of approx. 5...
20204BASEBIO AG : Notification and public disclosure of transactions by persons
2020EXPEDEON : 4basebio AG announces allotment ratio and final number of shares for the share ..
20204BASEBIO AG : 4basebio AG announces allotment ratio and final number of shares for the sha..
20204basebio AG's Equity Buyback announced on December 19, 2019, has closed with 5,584,558 ..
2020EXPEDEON : Notification of the allotment ratio for the share buy back
2020EXPEDEON : 4basebio AG announces results of the public share buyback offer and final purch..
20204BASEBIO AG : 4basebio AG announces results of the public share buyback offerand final pur..
2020AD HOC : 4basebio AG decides to increase the public share buyback offer volume from 2,056,..
2020EXPEDEON : 4basebio AG decides to increase the public share buyback offer volume from 2,05..
20204BASEBIO AG : 4basebio AG decides to increase the public share buyback offer volume from 2..
20204BASEBIO AG : 4basebio AG decides to increase the public share buyback offer volume from 2..
20204BASEBIO AG : 4basebio AG decides to buy back 2 million treasury shares
20204BASEBIO AG : 4basebio AG decides to buy back 2 million treasury shares for further use in..
20204BASEBIO AG : Expedeon AG completes change of name to 4basebio AG and of ticker symbol to ..
2020Expedeon AG has Changed its Name to 4basebio AG
2020ABCAM : announces successful acquisition of Expedeon's Proteomics and Immunology business,..
2020EXPEDEON : Abcam announces successful acquisition of Expedeon's Proteomics and Immunology ..
2020EXPEDEON : and Abcam plc close EUR 120 million transaction
2020EXPEDEON AG : Expedeon AG and Abcam plc close EUR 120 million transaction
2020Abcam plc completed the acquisition of TGR Biosciences Pty Ltd, Innova Biosciences Ltd...
2019EXPEDEON AG : Notification and public disclosure of transactions by persons
2019EXPEDEON AG : Notification and public disclosure of transactions by persons
2019EXPEDEON : shareholders approve sale of proteomics & immunotherapy business and name chang..
2019EXPEDEON AG : Expedeon shareholders approve sale of proteomics & immunotherapy business an..